drugset / Trial / NCT00420017
Prevention of Atrial Fibrillation Following Esophagectomy
Phase 4
Completed
80 enrolled
Indiana University
Indiana University Health · collabPurdue University · collab
RandomizedParallel-groupOpen-labelPrevention
Summary
The investigators hypothesize that the medication amiodarone decreases the incidence of atrial fibrillation (AF) following esophagectomy surgery. Their specific aims are to: Determine the effectiveness of amiodarone for the prevention of AF following esophagectomy surgery; Determine the influence of the prevention of AF following esophagectomy surgery on post-surgical duration of stay in the Intensive Care Unit ICU)and duration of post-surgical hospital stay; and Determine the safety of amiodarone for the prevention of AF following esophagectomy surgery.
Timeline
- Start
- 2005-09
- Primary completion
- 2008-11
- Completion
- 2008-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amiodarone | Small molecule | 4200 mg | Intravenous |